People's United Financial, Inc. - CELLDEX THERAPEUTICS INC NEW ownership

CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 141 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q3 2016. The put-call ratio across all filers is 1.05 and the average weighting 0.0%.

Quarter-by-quarter ownership
People's United Financial, Inc. ownership history of CELLDEX THERAPEUTICS INC NEW
ValueSharesWeighting
Q2 2017$3,000
-25.0%
1,2450.0%0.00%
Q1 2017$4,0000.0%1,2450.0%0.00%
Q4 2016$4,000
-20.0%
1,2450.0%0.00%
Q3 2016$5,0000.0%1,2450.0%0.00%
Q2 2016$5,0000.0%1,2450.0%0.00%
Q1 2016$5,000
-75.0%
1,2450.0%0.00%
-100.0%
Q4 2015$20,000
+53.8%
1,2450.0%0.00%0.0%
Q3 2015$13,000
-58.1%
1,2450.0%0.00%
-50.0%
Q2 2015$31,000
-11.4%
1,2450.0%0.00%0.0%
Q1 2015$35,000
+52.2%
1,2450.0%0.00%
+100.0%
Q4 2014$23,000
+43.8%
1,2450.0%0.00%0.0%
Q3 2014$16,000
-20.0%
1,2450.0%0.00%0.0%
Q2 2014$20,000
-9.1%
1,2450.0%0.00%0.0%
Q1 2014$22,000
-26.7%
1,2450.0%0.00%
-50.0%
Q4 2013$30,000
-31.8%
1,2450.0%0.00%
-33.3%
Q3 2013$44,000
+131.6%
1,2450.0%0.00%
+200.0%
Q2 2013$19,0001,2450.00%
Other shareholders
CELLDEX THERAPEUTICS INC NEW shareholders Q3 2016
NameSharesValueWeighting ↓
TSP Capital Management Group, LLC 844,981$15,421,0007.11%
DOHENY ASSET MANAGEMENT /CA 195,345$3,565,0001.70%
First Light Asset Management, LLC 153,617$2,804,0001.59%
Rhenman & Partners Asset Management AB 175,000$3,194,0000.93%
Iguana Healthcare Management, LLC 100,000$1,825,0000.88%
Eventide Asset Management 288,700$5,269,0000.58%
Bedell Frazier Investment Counselling, LLC 60,820$1,110,0000.54%
STONERIDGE INVESTMENT PARTNERS LLC 214,327$3,911,0000.52%
Fernwood Investment Management, LLC 31,350$572,0000.49%
SUFFOLK CAPITAL MANAGEMENT LLC 168,560$3,076,0000.37%
View complete list of CELLDEX THERAPEUTICS INC NEW shareholders